Despite Continued Stock Market Decline, a Few Life Science Tool Vendors Gained in November | GenomeWeb
NEW YORK (GenomeWeb News) – With stock markets continuing their declines throughout the month of November, most of the publicly traded life science tool vendors were not immune to the downturn. However, a handful managed gains for their stocks amid the difficult economic climate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.